# Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations

> **NCT00823654** · — · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 609 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** Blood draw and questionnaires
- **OTHER:** Blood draw and questionnaires

## Key facts

- **NCT ID:** NCT00823654
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2009-01
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 609 (ESTIMATED)
- **Last updated:** 2025-10-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00823654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00823654, "Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00823654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*